Posted by Michael Wonder on 21 Oct 2019
Voters beware: national pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers
18 October 2019 - Research has shown it would be less disruptive and less expensive to just fill the gaps caused by public formulary exclusions.
In a federal election that seems focused more on personality than policy, national pharmacare is one issue with huge consequences for voters and on which party positions diverge substantially.
Three parties favour a publicly funded, universal, national, single-payer drug program that will entirely replace existing private and public drug plans.
